Not applicableStudy completedNCT01160185What this trial is testingMeta-analysis of Efficacy of TopotecanWho this might be right forCervical Intraepithelial Neoplasia GlaxoSmithKline 1
Not applicableUnknownNCT05310305What this trial is testingPD-1 Antibody and Radiotherapy for Recurrent Cervical CancerWho this might be right forImmune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more Lei Li 20
Testing effectiveness (Phase 2)Study completedNCT03816553What this trial is testingSHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical CancerWho this might be right forRecurrent Cervical CarcinomaMetastatic Cervical Cancer Sun Yat-sen University 45
Testing effectiveness (Phase 2)Study completedNCT03427411What this trial is testingM7824 in Subjects With HPV Associated MalignanciesWho this might be right forHuman Papilloma VirusCervical CancerOropharyngeal Cancer+2 more National Cancer Institute (NCI) 57
Not applicableEnded earlyNCT00669422What this trial is testingChemoFx® PRO - A Post-Market Data Collection StudyWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer+5 more Precision Therapeutics 2,756
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Not applicableTemporarily pausedNCT03987555What this trial is testingPaclitaxel Therapeutic Drug Monitoring in Cancer PatientsWho this might be right forSolid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more Wake Forest University Health Sciences 55
Early research (Phase 1)Study completedNCT00287885What this trial is testingDocetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+5 more Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT01229930What this trial is testingCarboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by SurgeryWho this might be right forCervical Cancer University of Glasgow 130
Testing effectiveness (Phase 2)UnknownNCT04836663What this trial is testingTQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic TumorsWho this might be right forAdvanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00016926What this trial is testingCapecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerWho this might be right forCervical Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00610740What this trial is testingCerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial CancerWho this might be right forCervical CancerEndometrial CancerOvarian Cancer Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT00003017What this trial is testingInterleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the CervixWho this might be right forCervical Cancer Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00295789What this trial is testingTrial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)Who this might be right forUterine Cervical Neoplasms Haruhiko Fukuda 253
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07542717What this trial is testingASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 41
Testing effectiveness (Phase 2)Study completedNCT04868708What this trial is testingAK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Akeso 50
Testing effectiveness (Phase 2)WithdrawnNCT06099418What this trial is testingEfficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.Who this might be right forHPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer Nykode Therapeutics ASA
Testing effectiveness (Phase 2)Study completedNCT06226350What this trial is testingA Phase Ⅱ Study of F520 in Patients With Cervical CarcinomaWho this might be right forCervical Cancer Shandong New Time Pharmaceutical Co., LTD 29
Large-scale testing (Phase 3)Study completedNCT04697628What this trial is testingTisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Seagen, a wholly owned subsidiary of Pfizer 502
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797153What this trial is testingJSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Jiangsu Alphamab Biopharmaceuticals Co., Ltd 368